Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway

Version 1 : Received: 3 May 2020 / Approved: 5 May 2020 / Online: 5 May 2020 (12:08:59 CEST)

How to cite: Tang, H.; Bai, Y.; Xiong, L.; Wei, Y.; Hu, W.; Xu, M.; Zhou, X.; Pan, G.; Zhang, L.; Zhu, M.; Tang, Z.; Yang, Z.; Zhou, X.; Cai, Y.; Lanuti, M.; Zhao, J. Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway. Preprints 2020, 2020050077. https://doi.org/10.20944/preprints202005.0077.v1 Tang, H.; Bai, Y.; Xiong, L.; Wei, Y.; Hu, W.; Xu, M.; Zhou, X.; Pan, G.; Zhang, L.; Zhu, M.; Tang, Z.; Yang, Z.; Zhou, X.; Cai, Y.; Lanuti, M.; Zhao, J. Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway. Preprints 2020, 2020050077. https://doi.org/10.20944/preprints202005.0077.v1

Abstract

The signal transduction pathways of estrogen receptors (ER) mainly includes gene pathway and non-gene pathway. Studies have shown that the gene pathway of ER is related with the expression of nuclear proteins, and this is the key issue for our current research. With the GEO database analysis, Human centromere protein F (CENPF) is highly expressed in adenocarcinoma of lung (LUAD), and the co-expression of CENPF and ERβ was found in the nucleus of LUAD cells. Meanwhile, CENPF and ERβ2/5 were related with T stage and poor prognosis (P<0.05). Knockdown of CENPF gene significantly inhibited the biological effects of LUAD cells, the tumor growth of mice and the expression of ERβ2/5 (P<0.05). Further, group experiments showed that knockdown CENPF inhibits biological effects of LUAD cells mediated by ERβ pathway. All the results indicated that both CENPF and ERβ2/5 play important roles in the progression of LUAD, and knockdown of CENPF can inhibit the progression of LUAD by inhibiting the expression of ER2/5. Thus, the development of inhibitors against ERβ2/5 subtype and CENPF remained more effective in improving the therapeutic effect of LUAD.

Keywords

centromere protein F (CENPF); Estrogen Receptor beta; Lung Adenocarcinoma (LUAD); WGCNA package; non-small cell lung cancer (NSCLC)

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.